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Emergency Departments in Florida Hospitals
Evelyn P. Davila, MPH
WayWay M. Hlaing, MBBS, MS, PhD
ABSTRACT
Although essential hypertension (EHT) tends to coexist with other conditions, few studies have focused on
comorbidities and symptoms among patients admitted to emergency departments (ED). The objective was to
compare the characteristics, comorbidities and symptoms among patients with three types (unspecified, benign, or
malignant) of EHT in Florida. A public use data set of ED patients from the Florida Agency for Health Care
Administration (AHCA) from 2005 was used. Records included those with primary diagnosis of three types of EHT
based on the International Classification of Diseases, 9th edition (ICD-9) code. Group comparisons were made
using Chi square tests and linear regression models. Of 34,625 records, 96.3%, 2.0%, and 1.7% of them had
unspecified, benign and malignant EHT, respectively. Types of EHT varied significantly (p < .05) by race/ethnicity,
age group, health insurance status, discharge status, and length of stay. The most common secondary diagnoses
included diabetes, abnormal lipid metabolism, hypokalemia, and anemia. Whereas diabetes without complication
was the most common comorbidity of unspecified (10.7%) and malignant (12.6%) hypertensive patients, abnormal
lipid metabolism was the most common co-morbidity of benign (20.0%) hypertensive patients. The most frequent
symptom in all three groups was headache. About 60.0% (malignant), 34.6% (unspecified), and 4.2% (benign) of
patients’ main reason for ED visit were not related to their principal diagnosis. Variation in factors contributing to
comorbidities between three types of EHT should be further explored.
Florida Public Health Review, 2008; 5, 84-92.
Introduction
High blood pressure (HBP) or hypertension (HT)
is a risk factor for the two leading causes of death in
the United States (US), heart disease and stroke.
According to the Centers for Disease Control and
Prevention (CDC), HBP continues to affect about one
third of the US population (CDC, 2006). Moreover,
HT was responsible for 7.8 deaths per 100,000
population in 2004 (CDC, 2004). Although there are
several explanations for the high mortality and
burden associated with HT, one possible reason may
be due to the presence of multiple chronic conditions
among hypertensive adults.
For example,
comorbidities such as diabetes and chronic kidney
disease have been associated with uncontrolled blood
pressure (BP) (Trioli et al., 2004; Majernick et al.,
2004). Also, osteoarthritis and asthma have been
detected in patients with HT (Wang et al., 2005).
Hence, national and international HT management
guidelines have recommended lower BP targets for
individuals with target organ damage or other chronic
conditions (Trioli et al., 2004).
Whereas there is vast research on the prevalence,
treatment, and control of HT, comorbidities
associated with HT are relatively understudied.
Conceivably, patients admitted to the emergency
department (ED) in hospitals for HT may have

greater levels of uncontrolled HT compared with the
general population (Preston et al., 1999; Shayne &
Pitts 2003; Karras et al., 2005). Patients admitted to
the ED may present with conditions and symptoms
not observed in other hypertensive adults who were
not admitted to the ED. In addition, it is plausible that
comorbidities and symptoms would vary by severity
or subcategory of essential hypertension (EHT).
Because the ED is likely to be the primary source of
care for uninsured individuals, and uninsured
hypertensive individuals have shown greater odds for
uncontrolled BP, the ED provides a venue to assess
hypertensive individuals with greater risk of HT
complications (Tanabe et al., 2004; Duru et al.,
2007). Furthermore, because Florida is one of the
leading states in the country with a multi-ethnic
population, and the control of HBP has been shown
to vary by race and ethnicity, research on the
prevalence of comorbidities among HT patients
admitted in a Florida ED is warranted (U.S. Census
Bureau, 2000; Hajjar & Kotchen, 2003). This study
would be beneficial for future prevention programs
targeting groups at higher risk for complications
related to EHT. To the authors’ knowledge, there are
currently no published studies on comorbidity among
individuals admitted in ED for EHT and its subtypes
in Florida. This study examined the demographic
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and clinical characteristics of patients admitted to the
ED with EHT in Florida. Specifically, differences in
comorbidities and symptoms between patients
diagnosed with malignant, benign, and unspecified
EHT were compared.
Methods
Study Design
This study examined patients admitted with
primary diagnosis of EHT in emergency departments
(ED) of Florida hospitals in 2005.
Setting
The 2005 ED data from the Florida Agency for
Health Care Administration (AHCA) were used. No
personal identifiers appeared in the AHCA public use
file. All patient records in 2005 that were verified by
Florida hospitals and reported to AHCA by February
2007 were included. Florida hospitals have up to 18
months to check the accuracy of the data before
sending the data to the AHCA. Therefore, the current
data included all records of all Florida hospitals
reported to the AHCA by February 2007.
Sample
Records with primary diagnosis of three subcategories of EHT based on the International
Classification of Disease, 9th edition (ICD-9) code in
2005 were extracted. Specifically, ICD-9 codes of
401.0 or malignant EHT, 401.1 or benign EHT, and
401.9 or unspecified EHT were included. Malignant
EHT is defined as severe HT characterized by
necrosis of the small arteries and swelling of the optic
nerve or papilledema, with diastolic BP usually >130
mm Hg, and target organ damage. Benign EHT is
less severe than malignant EHT, without target organ
damage and is usually symptomless. If the subcategory of EHT is not specified, then it is coded as
unspecified EHT (Medical Terminology Dictionary,
2007; U.S. National Library of Medicine and
National Institute of Health, 2007).
Measures
The main outcome measures included the chief
reason for ED visit (complaint) and secondary
diagnoses. These variables were originally assigned
based on the ICD-9 codes. Each record may have one
primary diagnosis and up to nine secondary
diagnoses. Two new variables relating to the
symptoms of hypertension were created. Twelve
related symptoms based on the ICD-9 codes included
1) dizziness, 2) fatigue, 3) headache, 4) chest pain, 5)
elevated blood pressure 6) nosebleed, 7) tachycardia,
8) heart palpitations 9) unspecified, 10) blood in
urine, 11) blurred vision, and 12) others. These
symptoms were collapsed into a dichotomous
variable as having one or more of the eleven
symptoms (i.e., items 1 through 11 above) related to

hypertension versus none of the symptoms or others
(i.e., item 12). In addition, the reasons for ED visit
was dichotomized as reasons related to the primary
diagnosis (i.e., yes if malignant, benign, and
unspecified EHT) versus reasons unrelated to the
primary diagnosis or no. A new variable that
combined the reasons and symptom was then created;
if the reasons or symptoms were related to the
primary diagnosis, it was coded as yes or 1 and
records with reasons or symptoms not related to the
primary diagnosis was coded as no or 2.
Socio-demographic variables included in the
study were age, sex, race/ethnicity, and insurance
status. Age groups were created from the original age
variable as those < 25, 25-44, 45-64, 65-74, 75-84,
and > 85 years. The original race/ethnicity code was
categorized into four groups: 1) Blacks or African
Americans, 2) non-Hispanic Whites, 3) Hispanics,
and 4) others which included American
Indians/Alaskan Natives, and Asians or Pacific
Islanders. Insurance status was based on the original
principal payer variable that contained 16 categories.
These categories were collapsed into 5 categories: 1)
Commercial [Health Maintenance Organization
(HMO) and Preferred Provider Organization (PPO)],
2) Federal (Medicare, Civilian Health and Medical
Program of the Uniformed Services or Champus, and
Veterans Administration or VA), 3) State (Medicaid,
Workers Compensation, and other state/local
government), 4) Charity and underinsured, and 5)
others or uninsured (included those who did not have
any of the above health insurance). The original
discharge status included 10 categories which were
collapsed into 3 categories: 1) discharged home (i.e.,
those discharged to home care or a home healthcare
organization or discharged home on IV medications),
2) expired, and 3) discharged to another facility (i.e.,
those transferred to a short term general hospital, to a
skilled nursing facility, to an intermediate care
facility, to another sub-category of institution or
facility, and those that left against medical advice).
Length of hospital stay was recoded as a categorical
variable: less than one day versus one or more days.
Data analysis
Data analysis was performed using SPSS version
14 (Chicago IL). Records with EHT were stratified as
benign, malignant, and unspecified groups. Linear
regression models were used to assess variations in
hospital length of stay and age. Statistical tests (chisquare and F tests) were used to evaluate differences
in characteristics among EHT groups.
Results
Of the 5,546,999 ED records from the most
recently updated 2005 AHCA data, 0.62% or 34,625
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records had primary diagnosis of EHT. The mean and
standard error (SE) of age were 59.3 (+0.68) years,
61.7 (+ 0.58) years, and 57.6 (+ 0.09) years for
patients with malignant, benign, and unspecified
EHT, respectively (Data not shown). About 33,346
(96.3%) records had unspecified HT, while only 701
(2.0%) of records had benign and 578 (1.7%) had
malignant EHT (Table 1). Patients were
Table 1. Emergency Department (ED) Records with Essential
Hypertension in Florida, 2005 (n = 34,625)
Essential Hypertension types & (ICD-9 code)
n

%

Malignant (401.0)

578

1.7

Benign (401.1)

701

2.0

Unspecified (401.9)

33346

96.3

Sex#
Male

13812

39.9

Female

20812

60.1

Race/Ethnicity##
Black/African American

10644

31.4

White

18960

55.9

Hispanic

4040

11.9

Others

244

0.8

Age (years)
<25

627

1.8

25-44

7801

22.5

45-64

13572

39.2

65-74

5619

16.2

75-84

5086

14.7

>85

1920

5.6

Discharge Status
Discharged to Home

32899

95.5

Discharged to another care facility

1724

4.5

Expired

2

0

Commercial: HMO & PPO

9900

28.6

Federal: Medicare etc

13162

38.0

State: Medicaid etc

3154

9.1

Underinsured & Charity

8342

24.1

Uninsured

56

0.2

Commercial: HMO & PPO

9900

28.6

Federal: Medicare etc

13162

38.0

State: Medicaid etc

3154

9.1

Insurance Status

###

Insurance Status###

Underinsured & Charity

8342

24.1

Uninsured

56

0.2

Length of Stay
< 1 day

28938

83.6

> 1 day

5687

16.4

# missing =1

## missing = 737

### missing = 11

more likely to be female (60.1%), White (55.9%),
discharged home (95.5%), and have a hospital stay
<1 day (83.6%). About 38% had Medicare or other
Federal health insurance; 24.1% were underinsured.
There were no differences in gender distribution
by three type of EHT (Table 2). There were
statistically significant differences in race/ethnicity,
age group, discharge status, insurance status, and
length of stay between three types of EHT (p < .01).
Most patients were White, female, and 45-64 years of
age regardless of types of EHT. Less than one-third
of patients had commercial health insurance. Over
20% of patients with malignant and unspecified EHT
were underinsured whereas 8% of patients with
benign EHT were underinsured. There were only two
deaths among patients with unspecified EHT. Length
of stay of less than 1 day was more common among
patients with benign EHT (98.3%) than unspecified
(83.5%) or malignant (69.0%) EHT. More patients
with malignant (32.0%) EHT tended to stay longer
during ED visits compared with unspecified (16.5%)
and benign (1.7%) EHT patients.
The most frequent secondary diagnosis among
patients with malignant (12.6%) and unspecified
(10.7%) EHT was diabetes without complications
(Table 3). However, for benign EHT patients, the
most frequent secondary diagnosis was abnormal
lipid metabolism or lipid disorder (20.0%).
Regardless of EHT type, diabetes and lipid
metabolism disorders were the most frequent
secondary diagnoses among patients admitted to the
ED. When identifying the most frequent reason for
visiting the ED with hypertension-related symptom,
headache was found to be the most common among
patients with malignant (6.6%), benign (0.4%), and
unspecified (8.8%) EHT (Table 4). Interestingly,
elevated blood pressure without prior diagnosis of
hypertension (ICD-9 code 796.8) was also a frequent
symptom among malignant (4.3%), benign (0.4%)
and unspecified (5.7%) EHT.
In assessing the congruence between principal
diagnosis of EHT types and patients’ reason for ED
visit, only 40% of malignant and 65.4% of
unspecified EHT patients were able to identify their
principal diagnosis EHT types correctly (p < .01)
(Table 5). Most patients with benign (95.8%) EHT
correctly identified their principal diagnosis as
benign EHT. Thus, 60.0% patients with malignant
EHT and 34.6% of patients with unspecified EHT as
principal diagnoses were inconsistent with their
reasons for ED visit diagnoses. Moreover, malignant
(74.6%) compared with unspecified (76.6%) benign
(98.7%) EHT patients reported symptoms that were
not related to EHT during their ED visits.
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Table 2: Variations in Patient Characteristics by Types of Essential Hypertension: in Florida, 2005 (n = 34,625)
Essential Hypertension Types
Malignant
(n= 578)

Benign
(n=701)

Unspecified
(n=33,346)

n ( %)

n (%)

n (%)

Sex#
Male

208 (36.0)

293 (41.8)

13311 (39.9)

Female

370 (64.0)

408 (58.2)

20034 (60.1)

Race/Ethnicity##
Black/African
American

139 (24.91)

85 (12.3)

10420 (31.9)

White

355 (63.62)

603 (87.0)

18002 (55.2)

Hispanic

63 (11.3)

4 (0.6)

3973 (12.2)

Others

1 (0.2)

1 (0.1)

242 (0.7)

Age (years)
<25

3 (0.5)

9 (1.3)

615 (1.8)

25-44

117 (20.2)

99 (14.1)

7585 (22.8)

45-64

235 (40.7)

244 (34.8)

13093 (39.3)

65-74

102 (17.7)

196 (28.0)

5321 (16.0)

75-84

82 (14.2)

122 (17.4)

4882 (14.6)

>85

39 (06.7)

31 (4.4)

1850 (5.5)

Discharge Status
Discharged to Home

549 (95.0)

698 (99.6)

31652 (94.9)

Discharged to another care facility

29 (5.0)

3 (0.4)

1692 (5.1)

Expired

0 (0.0)

0 (0.0)

2 (0.0)

Insurance Status##

X2
4.749 a

P
ns

302.584 b

**

102.889 c

**

31.408 d

**

154.852 e

**

212.821a

**

Commercial: HMO & PPO
176 (30.4)

190 (27.1)

9534 (28.6)

240 (41.5)

399 (56.9)

12523 (37.6)

41 (7.1)

55 (7.9)

3058 (9.2)

120 (20.8)
1 (0.2)

57 (8.1)
0 (0.0)

8165 (24.5)
55 (0.1)

Federal: Medicare etc
State: Medicaid etc
Underinsured & Charity
Uninsured
Length of Stay
< 1 day

393 (68.0)

689 (98.3)

27856 (83.5)

> 1 day

185 (32.0)

12 (1.7)

5490 (16.5)

# missing = 1 ## missing= 737 ### missing =11
a
2 degrees of freedom (df); b 6 df; c 10 df; d 4 df; e 8 df
ns = not significant; * = p < .05; ** = p < .01
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Table 3: The most frequent Secondary Diagnoses by types of Essential Hypertension in Florida, 2005
Essential Hypertension Types

Malignant (n= 578)
Ranka

Disease & (ICD-9)

1

Diabetes
without
complications
(250.00)

2

Hypercholesterolemia
(272.0)

3

Metabolism/
lipid disorder
(272.4)

4

5

a

Benign (n=701)
n (%)

Unspecified (n=33,346)

Disease & (ICD-9)

n (%)

Disease & (ICD-9)

n (%)

73 (12.6)

Metabolism/
lipid disorder
(272.4)

142 (20.0)

Diabetes
without
complications
(250.00)

3569 (10.7)

29 (5.1)

Diabetes
without
complications
(250.00)

112 (16.0)

Hypercholesterolemia
(272.0)

1011 (3.0)

29 (5.1)

Hypercholesterolemia
(272.0)

87 (12.4)

Metabolism/
lipid disorder
(272.4)

595 (1.8)

Hypokalemia (276.8)

23 (4.0)

Obesity
(278.0)

52 (7.5)

Hypokalemia (276.8)

565 (1.7)

Obesity
(278.0)

10 (1.7)

Anemia (285.9)

26 (3.7)

Disorder
of
the
urethra or urinary
tract
(599.0)

511 (1.5)

Rank is based on frequency of diseases of secondary diagnoses. An individual record may have up to nine secondary diagnoses.

Discussion
Comorbidities among individuals with EHT are
understudied, possibly due to investigators using the
presence of comorbidities as an exclusion criterion in
studies (Fortin et al., 2006). Nevertheless,
comorbidities are high in many populations such as
the elderly and hypertensive adults (Wang et al.,
2005; Fortin et al., 2006; Fillenbaum et al., 2000).
For example, Wang et al. (2005) indicated that at
least 60% of the elderly population has multiple
chronic conditions. Conditions often associated with
HT in the general population include those related to
cardiovascular risk, such as diabetes, obesity, and
dyslipidemia (Majernick et al., 2004; Fortin et al.,
2006; Fillenbaum et al., 2000; Xu & Ragain, 2005;
Nothwehr & Perkins, 2002). Due to the scarcity of
studies relating to EHT-related comorbidities among
ED patients, consistency of the findings with the
current study cannot be evaluated.
The findings from this study indicated that subcategories or types of EHT varied significantly by
race and ethnicity, age group, discharge status,
insurance status, and length of stay. Furthermore,
frequencies of comorbidities varied by types of EHT.
Diabetes was the most common secondary diagnosis
in this study. It is plausible that patients with diabetes
have greater levels of uncontrolled HBP leading to an

ED visit. This finding is consistent with a study in
which greater odds for uncontrolled HBP was found
among ED patients with diabetes (Trioli et al., 2004).
In contrast, heart failure, a risk factor for ED visit
among hypertensive individuals, was not one of the
most common secondary diagnoses in Florida ED
patients (Tisdale et al., 2004). It is likely that patients
with heart failure in the current study were classified
as having secondary HT and would not be included
under primary or essential HT classification code.
Prevalence of other co-existing conditions also
differed by types of EHT. For instance, disorder of
the urethra tract was common among patients with
unspecified EHT while anemia was common among
patients with benign EHT. Interestingly, Fortin et al.
(2006) also found anemia to be a frequent diagnosis
in about 10% of the non-hospitalized population with
HT
In terms of symptoms, headache was the most
common complaint by patients with all three types of
EHT. Previous studies also have noted headache as a
common complaint among ED patients (Marco et al.,
2007; Gaini et al., 2004; Zampaglione et al., 1996;
Chiang & Jamshani., 1998). Along the same line, the
most common symptoms reported in this study were
also noted frequently in previous studies among ED
patients with elevated BP (Preston et al., 1999;
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Karras et al., 2005; Zampaglione et al., 1996). The
symptomatology results also indicated that many
hypertensive patients in this study were unaware that
they had HT since they had elevated BP without
previous diagnosis of HT as their reason for ED visit,
particularly among patients with malignant EHT.
This finding is surprising because diagnosis with
malignant EHT implies complications due to elevated
BP. Thus, it can be inferred that these patients did not
receive the aggressive treatment that patients with
malignant EHT would and should normally receive.
It is also possible that their EHT condition was not
diagnosed early enough or that a non-specific
symptom such as headache was ignored during their
visits to health care professionals. Furthermore,
although HT has been termed “the silent killer”
because of its lack of noticeable signs or symptoms,
this study revealed that about one-fourth of patients
with malignant or unspecified EHT reported HT
related symptoms (e.g. headache, chest pain, fatigue)
and those symptoms most frequent among EHT could
be considered warning signs of elevated BP. This
finding is consistent with a previous study where
26% of patients with elevated BP presented
symptoms such as chest pain, shortness of breath,
headache, and nosebleed (Karras et al., 2005).
Furthermore, patients with malignant EHT were
less likely to have agreement between their primary
diagnosis and their reason for ED visit. However, a
higher percent of HT related symptoms was reported
by patients with malignant EHT. These findings
implied that individuals with malignant EHT may not
only be more likely to have comorbidities and
uncontrolled HT, but also lack knowledge about HT.
This finding was supported by a study where lack of
high BP knowledge was associated with poor BP
control among ambulatory HT patients (Knight et al.,
2001). Not surprisingly, patients with malignant EHT
were more likely to stay more than one day during
ED visits than patients with benign or unspecified
EHT. Differences observed between malignant and
benign EHT in this study could partially be due a
greater percentage of minorities (Blacks and
Hispanics) representing with malignant EHT rather
than benign EHT. For example, incidence of
malignant HT has been shown higher among Blacks
than Whites of hospitalized patients in the
Netherlands (van den Born et al., 2006). Similarly,
non-Hispanic Blacks and Hispanics have shown
greater levels of uncontrolled HBP compared with
non-Hispanic Whites in the general population
(Hajjar & Kotchen, 2003). Among ED patients,
African Americans have also been found to have
greater BP levels compared with other ethnic groups
(Karras et al., 2005).

To our knowledge, this is the first study to
explore comorbidities among ED-admitted patients
with EHT in Florida. Strengths of this study were a
large sample size and the validity of the data on
comorbidities was greater compared to other studies
relying on self-reported disease information. The
accuracy of diagnoses in this study was enhanced by
using the standard ICD-9 codes used by trained
health personnel.
Several limitations of this cross-sectional study
should be noted. Primarily, there is the limitation in
access to other patient characteristics such as
measured BP value at ED admission, family history
of other chronic conditions, length or chronicity of
comorbid conditions, income, social support, use of
antihypertensive medications, lifestyle habits (e.g.
dietary and exercise), and frequency of ED visits.
This study only included records with primary
diagnosis of EHT, which are based on the primary
service received in the ED. Thus, individuals with
EHT that visited the ED primarily for reasons other
than EHT were excluded. Since personal identifiers
were not available, an individual that was admitted to
ED more than once could not be identified. The
patient population was restricted to those visited ED
only in 2005. Thus, patients with EHT who visited
outpatient departments or inpatient acute-care
hospitals were not included.
Conclusion
In summary, the most common comorbidities
among ED patients with EHT were diabetes and
metabolism lipid disorder, particularly among
patients with malignant and unspecified EHT.
Symptoms and signs such as headache and elevated
BP were the most common and were mainly reported
by patients with malignant or unspecified EHT.
Patients with malignant EHT were more likely than
patients with unspecified or benign EHT to be black
or African American and provided a reason for ED
visit inconsistent with the primary diagnosis type.
Previous studies have shown an association of
comorbidity with uncontrolled HBP among HT
patients (Trioli et al., 2004; Preston et al., 1999;
Shayne et al., 2003; Karras et al., 2005). However, it
is not known if the ED patients with co-existing
conditions and symptoms related to EHT in this study
were unaware of or had uncontrolled HBP.
Nevertheless, improved HT management and health
education of HT related topics may be beneficial to
the ED patients in Florida. Future studies should
evaluate differences in presence of these conditions
and symptoms by various patient characteristics
among hypertensive patients, particularly differences
by race/ethnicity.
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Implications
The findings from this study have the important
implications for both medical and public health
professionals interested in the prevention and control
of hypertension and related complications. Few
studies have focused on comorbidities and symptoms
among patients admitted to emergency departments
(ED) with EHT, yet identifying comorbidities may
influence the management of hypertension. Based on
our results, conditions most likely to coexist with

EHT among Florida patients included diabetes and
lipid metabolism disorder. Conceivably, management
of EHT may be improved if these coexisting chronic
diseases are detected and controlled early. Prevention
programs and interventions that educate individuals
about symptoms associated with hypertension may
not only increase awareness of high blood pressure,
but may also increase awareness of when
management is not being effective among diagnosed
hypertensives.

Table 4: The most frequent Reason (patients’ complaint) for ED by types of Essential Hypertension in Florida, 2005
Essential Hypertension Types

Malignant (n= 578)

Benign (n=701)

Unspecified (n=33,346)

Ranka

Reason &
(ICD-9)

n (%)

Reason &
(ICD-9)

N (%)

Reason &
(ICD-9)

n (%)

1

Headache
(780.0)

38 (6.6)

Headache
(780.0)

3 (0.4)

Headache
(780.0)

2954 (8.8)

2

Chest pain
(786.50)

36 (6.2)

Elevated
BP
hypertension
(796.2)

3 (0.4)

Elevated
BP
hypertension
(796.2)

3

Dizziness
(780.4)

26 (4.5)

Dizziness
(780.4)

2 (0.3)

Chest pain
(786.50)

628 (1.8)

4

Elevated
BP
hypertension
(796.2)

25 (4.3)

Chest pain
(786.50)

1 (0.1)

Fatigue
(780.79)

449 (1.3)

5

Fatigue
(780.79)

10 (1.7)

NA b

Palpitations
(785.1)

156 (0.4)

a

without

without

without

1907 (5.7)

Rank is based on frequency of a primary reason ICD-9 code. b Only 4 symptoms related to Benign EHT. Thus, 5th rank symptom is NA.
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Table 5: Comparison between Principal Diagnosis and Patients’ Reason for Emergency Department (ED) Visit
Principal Diagnosis: Essential Hypertension (EHT) Types
Malignant
(n= 578)
n (%)

Benign
(n=701)
n (%)

Unspecified
(n=33346)
N (%)

X2

p

46252.76a

**

192.02b

**

75.195b

**

Reason for ED visit based on
EHT Type
401.0: Malignant

( 0)

5 (0.0)

5 ( 0.86)

672 (95.8)

3 (0.0)

401.9: Unspecified

120 (20.76)

13 ( 1.9)

21786 (65.4)

Other

222 (38.38)

16 ( 2.3)

11552 (34.6)

Yes

147 (25.4)

9 ( 1.3)

7814 (23.4)

No

431 (74.6)

692 (98.7)

25532 (76.6)

Yes

503 (87.0)

694 (99.0)

29608 (88.8)

No

75 (13.0)

7 (1.0)

3738 (11.20)

401.1: Benign

231 (40.0)

0

Reason for ED visit based on
symptoms related to EHT

Reason for ED visit based on
types of or symptoms related to
EHT

a

6 degrees of freedom (df); b 2 df

ns = not significant; * = p <0.05; ** = p <0.01
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